Mental Health
01 Jan 2013
Deep Brain Stimulation for Parkinson’s Disease Trial
The purpose of this trial is to evaluate the effect of deep brain stimulation in the the globus pallidus (Gpi) and the subthalamic nucleus (STN) on motor, neuropsychological and psychiatric function, and quality of life in patients with Parkinson’s disease. Official Title Deep Brain Stimulation for Parkinson’s Disease Trial.
Cancer
01 Jan 2013
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That is Metastatic to the Brain
Rationale: Drugs used in chemotherapy use different ways to stop tumour cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumour cells. It is not yet known if chemotherapy is more effective with or without radiation therapy in treating brain metastases.Purpose: Randomised phase…
Children's health
01 Jan 2013
Evaluation of a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox.
A study to evaluate GlaxoSmithKline Biologicals’ live attenuated varicella vaccine and GlaxoSmithKline Biologicals’ combined measles-mumps-rubella-varicella vaccine in the prevention of varicella disease in children. Official Title Study in Healthy Children (<2 Years) to Evaluate the Safety & Efficacy of GSK Biologicals’ Live Attenuated Varicella Vaccine (Varilrix) & of GSK Biologicals’…
Men's Health
01 Jan 2013
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes. Official Title A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes. Conditions Herpes Genitalis Study Type Interventional Study Design Treatment, Randomised, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment,…
Bone
01 Jan 2013
A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
The purpose of this trial is to evaluate the effectiveness (level of pain control) and safety of orally administrated CG5503 Extended Release (ER) (base) at doses of 100-250 mg twice daily in patients with moderate to severe chronic pain due to osteoarthritis of the knee, in comparison with placebo and…
Bone
01 Jan 2013
Pamidronate to Treat Osteogenesis Imperfecta in Children
This study will evaluate the effect of pamidronate-a drug that decreases bone resorption (breakdown)-on osteogenesis imperfecta. This is a genetic disorder of collagen, the major protein in bone. The abnormal collagen causes weak bones, and children with severe osteogenesis imperfecta sustain many fractures throughout their lives. They also have growth…
Bone
01 Jan 2013
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Haematologic Cancers or Other Diseases
Rationale:Listening to relaxing music during a bone marrow biopsy may be effective in reducing anxiety and pain.Purpose:This randomised clinical trial is studying how well music works in reducing anxiety and pain in adult patients undergoing bone marrow biopsy for haematologic cancers or other diseases. Official Title Use of Music to…
Bone
01 Jan 2013
Cytokine Gene Polymorphisms in Bone Marrow Failure
This study will examine whether cytokine gene polymorphisms affect the progression or response to therapy of bone marrow failure disorders. Cytokine genes instruct cells to produce proteins called cytokines that influence immune system response. As with many genes, the cytokine genes differ slightly from person to person. These differences are…
Research and Trials
01 Jan 2013
Alemtuzumab to Treat Severe Aplastic Anaemia
This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath®), in patients with severe aplastic anemia (SAA). SAA is a rare and serious blood disorder in which the bone marrow stops making red blood cells, white blood cells and platelets. Alemtuzumab is a monoclonal antibody…
